Investigational mRNA COVID-19 and Flu Vaccine Study

Now Enrolling in Cincinnati (Springdale), Lincoln, Portsmouth, and Rockville

Now Enrolling

About this research study

Velocity Clinical Research is now seeking participants for an investigational mRNA COVID-19 booster vaccine.

Eligible participants...

  • Must be age 18 to 49
  • Must have previously received a primary series of an authorized/approved COVID-19 vaccine (last COVID-19 vaccine must have been received at least 120 day ago)
  • Must NOT have tested positive for COVID-19 within the past 90 days
  • Must NOT have received an influenza vaccine or tested positive for influenza within the past 150 days
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Cincinnati (Springdale), Ohio • Velocity Clinical Research

375 Glensprings Dr 2nd Floor, Cincinnati, OH 45246
Phone: (513) 671-8080

Lincoln, Nebraska • Velocity Clinical Research

4600 Valley Rd., Lincoln, NE 68510
Phone: (531) 530-2800

Suffolk, Virginia • Velocity Clinical Research

7007 Harbor View Blvd, Suite 109, Suffolk, VA 23435
Phone: (757) 996-4200

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy